CONGENITAL DEFICIENCY OF COAGULATION FACTOR VII IN THE SOUTH OF TUNISIA: ABOUT 88 CASES.

EHA Library, Safouan Kacem, 266722

A RETROSPECTIVE ANALYSIS OF IMMUNE THROMBOCYTOPENIA PATIENTS TREATMENT RESULTS AFTER SEQUENTIAL SWITCHING OF THROMBOPOIETIC RECEPTOR-AGONISTS

EHA Library, Maria Pankrashkina, 266723

IMPACT OF SEVERITY OF THE DISEASE AND FVIII INHIBITOR ON BONE MINERAL DENSITY AND BONE TURNOVER MARKER IN CHILDREN WITH HEMOPHILIA A

EHA Library, Panagiota Xafaki, 266724

CLINICAL FEATURES AND TREATMENT OUTCOMES OF ACQUIRED HEMOPHILIA A IN KOREA: RETROSPECTIVE ANALYSIS.

EHA Library, K S Lee, 266725

DENTAL HEALTH STATUS IN PATIENTS WITH HEMOPHILIA. SINGLE CENTER EXPERIENCE IN ROMANIA.

EHA Library, Emilia Ursu, 266726

THE IDENTIFICATION OF A COMMON LOSS-OF-FUNCTION MUTATION ACROSS DIFFERENT HLA CLASS ALLELES FREQUENTLY DETECTED IN PATIENTS WITH ACQUIRED APLASTIC ANEMIA

EHA Library, Hiroki Mizumaki, 266727

QUANTIFICATION OF METABOLITES IN DRIED BLOOD SPOTS OF DIAMOND BLACKFAN ANEMIA PATIENTS REVEALS NOVEL INSIGHTS IN DEREGULATED CELLULAR PATHWAYS INVOLVED IN HYPOPLASTIC ANEMIA.

EHA Library, Birgit van Dooijeweert, 266728

OLIGOCLONALITY OF T-CELL RECEPTOR AND THE MAIN SUBPOPULATION COMPOSITION IN PATIENTS WITH APLASTIC ANEMIA AT DIFFERENT STAGES OF THE DISEASE.

EHA Library, Anastasia Abramova, 266730

PATIENTS WITH GAUCHER DISEASE SHOW AN IMMUNE-DYSREGULATION PATTERN SECONDARY TO A DEFECT OF APOPTOSIS

EHA Library, Maurizio Miano, 266731

THE RELATIONSHIP BETWEEN THE PRETREATMENT PNH CLONE SIZE AND CLINICAL COURSE IN PATIENTS WITH BONE MARROW FAILURE SYNDROMES: INTERIM ANALYSIS OF JAPANESE MULTICENTER PROSPECTIVE STUDY

EHA Library, Yasutaka Ueda, 266732

LATE ONSET NEUTROPENIA ASSOCIATED WITH RITUXIMAB. FREQUENCY AND RISK FACTORS IN A COHORT OF PATIENTS WITH NON HODGKIN LYMPHOMA AT INSTITUTO NACIONAL DE CANCEROLOGÍA MÉXICO.

EHA Library, Myrna Candelaria, 266733

NO CHANGE IN THE EFFECTIVENESS OF IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH PNH AND AA RECEIVING CONCOMITANT ECULIZUMAB

EHA Library, Anita Hill, 266734

IDENTIFICATION OF MIRNA SIGNATURES CORRELATING WITH CLINICAL OUTCOMES IN APLASTIC ANAEMIA

EHA Library, Lynette Chee, 266735

PNH CLONE SIZE BY FLOW CYTOMETRY AND ITS CORRELATION TO PIG GENE MUTATION

EHA Library, Dajeong Jeong, 266736

IRON MOBILIZATION IN A REAL LIFE COHORT OF APLASTIC ANEMIA PATIENTS TREATED WITH ELTROMBOPAG

EHA Library, Francesca CAVALLARO, 266737

ABSENCE OF GPI-NEGATIVE CELLS AT DIAGNOSIS AND LOW NEUTROPHIL COUNT 2 MONTHS AFTER ATGAM BASED TREATMENT ARE ASSOCIATED WITH LOWER 6-MONTH RESPONSE RATE IN ADULTS WITH (VERY) SEVERE APLASTIC ANEMIA

EHA Library, Jennifer Tjon, 266738

RECURRENT XPO1 MUTATIONS IDENTIFIED AS PREDICTIVE MARKER FOR ADVANCED CLL PROGRESSION

EHA Library, Janek Walker, 266739

IMPACT OF MAJOR GENOMIC ALTERATIONS ON OUTCOME OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH VENETOCLAX PLUS RITUXIMAB IN THE PHASE 3 MURANO STUDY

EHA Library, Jenny Wu, 266740

IBRUTINIB TREATMENT ALTERS ENHANCER ACTIVITY PATTERNS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Efterpi Kostareli, 266741

LINKING MICROENVIRONMENTAL SIGNALS TO METABOLIC SWITCHES AND IBRUTINIB RESPONSE IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Zhenghao Chen, 266742

JNK1: AN EMERGING THERAPEUTIC TARGET IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) DOWNSTREAM OF THE B-CELL RECEPTOR, WHICH OVERCOMES IBRUTINIB RESISTANCE

EHA Library, Sarah Decker, 266743

SF3B1 MUTATIONS ASSOCIATE WITH LOW CD20 EXPRESSION IN CLL: ANOTHER NOTCH1-DEPENDENT MECHANISM?

EHA Library, Federico Pozzo, 266744

FUNGI INFECTION VERSUS IBRUTINIB TREATMENT: ROLE OF NURSE-LIKE CELLS DURING ASPERGILLUS FUMIGATUS INFECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Stefania Fiorcari, 266745

CLL- DERIVED EXOSOMES REPROGRAM RESIDENT CELLS TO BECOME CLL SUPPORTIVE CELLS

EHA Library, Orit Uziel, 266746

STEM CELL FACTOR IS IMPLICATED IN MICROENVIRONMENTAL INTERACTIONS AND CELLULAR DYNAMICS OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, George Gavriilidis, 266747

HIGH-THROUGHPUT Β-CELL IMMUNOPROFILING AT DIAGNOSIS AND RELAPSE OFFERS FURTHER EVIDENCE OF FUNCTIONAL SELECTION THROUGHOUT THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Anna Vardi, 266748

INHERITED DNA REPAIR AND CELL CYCLE GENE DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Jennifer R. Brown, 266749

GENOMIC ARRAYS IDENTIFY HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA WITH GENOMIC COMPLEXITY: A MULTI-CENTER STUDY

EHA Library, Alexander Leeksma, 266750

CHRONIC LYMPHOCYTIC LEUKEMIA CELLS IMPAIR MITOCHONDRIAL FITNESS IN T CELLS AND IMPEDE CAR T CELL EFFICACY

EHA Library, Jaco van Bruggen, 266751

MONOCYTIC BUT NOT GRANULOCYTIC MDSCS INCREASE WITH IBRUTINIB BUT NOT ACALABRUTINIB TREATMENT IN EM-TCL1 MICE WITH CLL, SUGGESTING A ROLE FOR ITK INHIBITION IN MONOCYTIC MDSCS

EHA Library, Arantxa Romero-Toledo, 266752

THE PI3KD-SELECTIVE INHIBITOR IDELALISIB INDUCES T AND NK CELL DYSFUNCTION INDEPENDENT OF B-CELL MALIGNANCY-ASSOCIATED IMMUNOSUPPRESION

EHA Library, Lisa Rohrbacher, 266753

COMPLEX STRUCTURAL VARIANTS LEAD TO GENE INACTIVATION RATHER THAN EXPRESSION OF DE NOVO FUSION GENES IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Karla Plevova, 266754

TUMOR MUTATIONAL BURDEN ASSESSED BY TARGETED HIGH THROUGHPUT SEQUENCING PREDICTS TREATMENT FREE SURVIVAL IN CLL: RESULTS FROM A BICENTER STUDY

EHA Library, Jasmine Chauzeix, 266755

P300 INDUCES STAT3 ACETYLATION AND PROVIDES CLL CELLS WITH SURVIVAL ADVANTAGE

EHA Library, Uri ROZOVSKI, 266756

THE IMBALANCE OF THE NON-LEUKEMIC COMPARTMENT SUSTAINS THE LYMPHOPROLIFERATION IN T-LARGE GRANULAR LYMPHOCITYES LEUKEMIA

EHA Library, Cristina Vicenzetto, 266757

PROTEOMICS MARKERS PROGNOSTIC FOR OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER TREATMENT; RESULTS FROM THE HOVON-109 STUDY

EHA Library, Fatemeh Saberi Hosnijeh, 266758

DEVELOPMENT OF 3D DRUG-TESTING PLATFORM FOR CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Hana Svozilova, 266759

AUTOIMMUNIZATION TO PLATELET ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Isaeva Natalia, 266760

TARGETING IRAK4 DISRUPTS INFLAMMATORY PATHWAYS AND DELAYS TUMOR DEVELOPMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Laia Rosich Moya, 266761

TARGETED ACTIVATION OF THE PROTEIN PHOSPHATASES SHP-1 AND PP2A ABROGATES CONSTITUTIVE ACTIVATION OF SURVIVAL PATHWAYS IN LARGE GRANULAR LYMPHOCYTE LEUKEMIA (LGLL)

EHA Library, Mario Pagano, 266762

LOW-COVERAGE WHOLE GENOME SEQUENCING OUTPERFORMS FISH IN COPY NUMBER VARIATION DETECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Beñat Ariceta, 266763

SPATIAL HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKAEMIA ANALYSED BY WHOLE-GENOME/EXOME SEQUENCING AT DIAGNOSIS

EHA Library, Ferran Nadeu, 266764

PRELIMINARY RESULTS OF A PHASE 1B/2 DOSE-ESCALATION AND COHORT-EXPANSION STUDY OF THE NONCOVALENT, REVERSIBLE BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), VECABRUTINIB, IN B-CELL MALIGNANCIES

EHA Library, John Allan, 266765

SECOND CANCER INCIDENCE IN CLL PATIENTS RECEIVING BTK INHIBITORS

EHA Library, David Bond, 266766

A PHASE 1 DOSE ESCALATION STUDY OF ARQ 531 IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL LYMPHOID MALIGNANCIES

EHA Library, Jennifer Woyach, 266767

PHASE 2 STUDY OF ACALABRUTINIB IN IBRUTINIB-INTOLERANT PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Kerry Rogers, 266768

THE USE OF THE BCL-2 INHIBITOR IN CLL PATIENTS WHO PROGRESSED AFTER B-CELL-RECEPTOR INHIBITORS: A RETROSPECTIVE MULTICENTER ITALIAN EXPERIENCE

EHA Library, Luca Laurenti, 266769

IMPACT OF COMORBIDITIES ON OUTCOMES OF THERAPY WITH IDELALISIB (IDELA), A PHOSPHOINOTISIDE-3 KINASE-DELTA INHIBITOR, IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Max Gordon, 266770

INFECTIONS IN CLL PATIENTS RECEIVING IBRUTINIB: INCIDENCE AND PREDISPOSING FACTORS

EHA Library, Eugene NIKITIN, 266771

A PHASE I/II STUDY OF THE SYK INHIBITOR ENTOSPLETINIB IN COMBINATION WITH OBINUTUZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Alexey Danilov, 266772

HAMPERED EFFECTIVENESS OF SECOND-LINE TREATMENT WITH RITUXIMAB-BASED CHEMOTHERAPY WITHOUT SIGNS OF RITUXIMAB RESISTANCE: A POPULATION-BASED STUDY AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Lina van der Straten, 266773

EFFECT OF DOSE MODIFICATIONS ON RESPONSE TO DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL/SLL IN THE DUO TRIAL

EHA Library, Paolo Ghia, 266774

IBRUTINIB PLUS RITUXIMUB IN STEROID REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA: ELABORATION OF TREATMENT APPROACH (ISRAEL): AN INTERIM ANALYSIS OF THE ROHS TRIAL

EHA Library, Eugene NIKITIN, 266775

POOLED ANALYSIS OF SAFETY DATA FROM MONOTHERAPY STUDIES OF THE BRUTON TYROSINE KINASE (BTK) INHIBITOR, ZANUBRUTINIB (BGB-3111), IN B-CELL MALIGNANCIES

EHA Library, Constantine S. Tam, 266776

PATTERNS OF DUVELISIB-INDUCED LYMPHOCYTOSIS IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA INCLUDING THOSE WITH HIGH-RISK FACTORS TREATED IN THE DUO TRIAL

EHA Library, Jacqueline Barrientos, 266777

EFFICACY AND SAFETY OF IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS PREVIOUSLY TREATED WITH VENETOCLAX IN THE MURANO STUDY

EHA Library, Richard Greil, 266778

COMBINATION THERAPY TO PREVENT IBRUTINIB WITHDRAWAL: CONTINUED IBRUTINIB WITH THE ADDITION OF VENETOCLAX AT TIME OF PROGRESSION IN IBRUTINIB-TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Paul Hampel, 266779

PATIENT-BASED PROSPECTIVE REAL WORLD DATA ANALYSIS SHOWS THAT THE DURATION OF TREATMENT INTERRUPTIONS WITH SUBSEQUENT RESUMPTION OF IDELALISIB THERAPY CAN VARY FROM DAYS TO MONTHS

EHA Library, Manuela Hoechstetter, 266780

SURVIVAL DISPARATIES IN HAIRY CELL LEUKEMIA ACROSS EUROPE: RESULTS OF RARECARENET--A POPULATION-BASED STUDY

EHA Library, Avinash Dinmohamed, 266781

VENETOCLAX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A RETROSPECTIVE CHART REVIEW OF SAFETY AND EFFICACY FROM PRE-APPROVAL ACCESS (PAA) PROGRAMS IN THE EUROPEAN UNION

EHA Library, Anna Schuh, 266782

LONGITUDINAL TREATMENT PATTERNS AND OUTCOMES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN ISRAEL (2009-2018)

EHA Library, Ran Afik, 266783

INDIVIDUAL RESPONSE OF CML PATIENTS TO TKI DOSE REDUCTION CAN RELIABLY IDENTIFY PATIENTS WITH HIGH RISK OF MOLECULAR RELAPSE AFTER TREATMENT CESSATION

EHA Library, Andrea Gottschalk, 266784

CHROMATIN TOPOLOGY AND THREE-DIMENSIONAL ORGANIZATION OF CHROMOSOME TERRITORIES 9 AND 22 IN CD34+ BONE MARROW CELLS FROM CHRONIC MYELOID LEUKEMIA PATIENTS.

EHA Library, Eunice Fabian-Morales, 266785

CYTOKINE AND ARGINASE-1 EXPRESSION DYNAMICS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA REVEALS EARLY MOLECULAR RESPONSE TO IMATINIB

EHA Library, Alicia Enrico, 266786

INFLUX/EFFLUX TRANSPORTERS IN CHRONIC MYELOID LEUKEMIA: THE INFLUENCE OF GENETIC VARIANTS ON SUSCEPTIBILITY AND DRUG RESPONSE

EHA Library, Ana Bela Sarmento-Ribeiro, 266787

TELOMERE LENGTH AT DIAGNOSIS OF CHRONIC MYELOID LEUKEMIA PREDICTS THE ACHIEVEMENT OF DEEP MOLECULAR RESPONSE TO IMATINIB

EHA Library, Natalia Estrada, 266788

DDPCR AT THE TIME OF TKI DISCONTINUATION IN CHRONIC PHASE CHRONIC MYELOID PATIENTS IS PREDICTIVE OF TREATMENT-FREE REMISSION OUTCOME

EHA Library, Gioia colafigli, 266789

PROTEIN CASEIN KINASE 2 IS INVOLVED IN CHRONIC MYELOID LEUKEMIA RESISTANCE TO IMATINIB AND ALSO TO DASATINIB

EHA Library, Ondřej Mitrovský, 266790

MTORC2 ACTIVATION AND AKT NUCLEAR LOCALIZATION UNDER HYPOXIA COULD SUSTAIN THE LEUKEMIA CANCER STEM CELLS

EHA Library, Cristina panuzzo, 266791

DETECTING BCR-ABL AND SCORING MR: RESULTS FROM A CE-IVD KIT RUN ON NON-IVD PCR INSTRUMENTS: A COMPARISON WITH DATA FROM A EUTOS VALIDATED LAB.

EHA Library, Jesper Petersen, 266792

PRIMARY RESULTS OF THE PHASE 4 BYOND STUDY OF BOSUTINIB FOR PRETREATED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

EHA Library, Andreas Hochhaus, 266793

PROGNOSTIC FACTORS FOR MOLECULAR RELAPSE-FREE SURVIVAL AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA BASED ON RUSSIAN MULTICENTER PROSPECTIVE TRIAL (RU-SKI)

EHA Library, Oleg Shukhov, 266794

TREATMENT AND OUTCOME OF CHRONIC MYELOID LEUKEMIA IN CHILDREN AND ADOLESCENTS: THE INDIAN PEDIATRIC ONCOLOGY GROUP-CML-16-01 MULTICENTRIC STUDY

EHA Library, Sidharth Totadri, 266795

TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA PATIENTS HARBORING ATYPICAL BCR-ABL1 TRANSCRIPTS

EHA Library, Matteo Dragani, 266796

FOLLOW-UP OF LOWER DOSE DASATINIB 50MG DAILY AS FRONTLINE THERAPY IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP)

EHA Library, Kiran Naqvi, 266797

DOSING PATTERNS OF DASATINIB AND NILOTINIB USE IN SIMPLICITY, AN OBSERVATIONAL STUDY IN CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS (PTS) IN ROUTINE CLINICAL PRACTICE

EHA Library, Carlo Gambacorti-Passerini, 266798

REAL WORLD TYROSINE KINASE INHIBITOR TREATMENT PATHWAYS, MONITORING PATTERNS AND RESPONSES COMPARED WITH ELN RECOMMENDATIONS IN CHRONIC MYELOID LEUKAEMIA: FINAL ANALYSIS OF THE UK TARGET CML STUDY

EHA Library, Adam Mead, 266799

THE POTENTIAL IMPACT OF SWITCH TO SECOND GENERATION TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS IN CHRONIC PHASE WHO HAD NO OPTIMAL RESPONSE TO 3 MONTHS OF INITIAL IMATINIB THERAPY

EHA Library, Maria Pankrashkina, 266800

ANALYSIS OF BCR-ABL1 TRANSCRIPT LEVELS AT 3 MONTHS IN PREDICTING OVERALL RESPONSE IN PATIENTS OF CHRONIC MYELOID LEUKEMIA- CHRONIC PHASE ON 1ST LINE THERAPY WITH IMATINIB MESYLATE

EHA Library, Asif Iqbal, 266801

FACTORS INFLUENCING PATIENT PREFERENCES FOR DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA.

EHA Library, Bogdan Ochrem, 266802

CURRENT DOSE RECOMMENDATIONS FOR PONATINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS CAN DIMINISH ADVERSE EVENTS WHILE MAINTAINING EFFICACY

EHA Library, Valentin Garcia-Gutierrez, 266803

ASSOCIATION OF CELLULAR IMMUNITY WITH MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS ON TYROSINE KINASE INHIBITORS THERAPY

EHA Library, Milan Jagurinoski, 266804

AN UPDATED META-ANALYSIS OF THE RISKS OF ARTERIAL AND VENOUS OCCLUSIVE EVENTS WITH NEW GENERATION BCR-ABL TKIS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA

EHA Library, Jonathan Douxfils, 266805

EXTENSIVE CLINICAL RESPONSE EVALUATION TOWARD OPTIMIZING IMATINIB DOSE FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA IN EASTERN ASIAN PATIENTS

EHA Library, HyeJin Shin, 266806

R-INTERFERON TREATMENT BEFORE TKI START IMPROVES TREATMENT FREE REMISSION RATE (TFR) PARTICULARLY IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH THE LESS FAVORABLE E13A2 BCR-ABL1 TRANSCRIPT TYPE

EHA Library, Mariella D'Adda, 266807

PROGNOSTIC SIGNIFICANCE OF REGULATORY T CELLS (TREGS) IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH GENERIC IMATINIB

EHA Library, Fen Saj, 266808

INITIAL REPORT OF A NILOTINIB DISCONTINUATION PROJECT WITH 54 GREEK CML PATIENTS FOLLOWED IN ACCORDANCE TO THE APPROVED DISCONTINUATION INDICATION OF THE DRUG

EHA Library, Maria Dimou, 266809

CHARACTERISTICS AND OUTCOMES OF THE TREATMENT PATIENTS WITH T315I MUTATION CML

EHA Library, Yulia Vlasova, 266810

AGE ≥59 YEARS IS ASSOCIATED WITH A HIGHER PROBABILITY OF CARDIOVASCULAR EVENTS IN PATIENTS RECEIVING NILOTINIB FOR CML: A SINGLE CENTRE RETROSPECTIVE ANALYSIS.

EHA Library, Ramzan Bilal, 266811

TIME TO HEALTH-RELATED QUALITY OF LIFE IMPROVEMENT IN THE PHASE 3 BFORE TRIAL: FIRST-LINE BOSUTINIB VS IMATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

EHA Library, Tim H Brümmendorf, 266812

INNOVATIVE DIAGNOSTIC APPROACH FOR RARE ANEMIA

EHA Library, Valeria Rizzuto, 266813

ASSESSING THE EMA BINDING TEST AND OSMOTIC GRADIENT EKTACYTOMETRY IN THE DIAGNOSIS OF HEREDITARY SPHEROCYTOSIS DEFINED BY THE PRESENCE OF UNDERLYING DIAGNOSTIC MUTATIONS

EHA Library, Andreas Glenthøj, 266814

MOLECULAR DIAGNOSIS OF RARE CONGENITAL ANEMIAS USING TARGETED NEXT-GENERATION SEQUENCING IN INDIAN PATIENTS

EHA Library, Rashmi DONGERDIYE, 266815

SCREENING FOR HEREDITARY SPHEROCYTOSIS IN DAILY PRACTICE: WHICH IS THE BEST ALGORITHM USING ERYTHROCYTE AND RETICULOCYTE PARAMETERS?

EHA Library, Anne-Sophie Adam, 266816

IDENTIFICATION OF MUTATIONS IN RED CELL MEMBRANOPATHIES USING NGS-TARGETED SEQUENCING PANEL

EHA Library, Tejashree More, 266817

: MOLECULAR STUDY OF RED CELL NADH-CYTOCHROME B5 REDUCTASE DEFICIENCY IN 21 INDIAN PATIENTS WITH RECESSIVE HEREDITARY METHEMOGLOBINAEMIA

EHA Library, Prabhakar Kedar, 266818

DIFFERENTIAL DIAGNOSIS OF CONGENITAL HEMOLYTIC ANEMIA OF NEONATES AND INFANTS IN JAPAN

EHA Library, J Howard, 266819

Hereditary spherocytosis: screening and diagnostic approach in a Belgian laboratory

EHA Library, Edith Sepulchre, 266820

SEVERE HEREDITARY HAEMOLYTIC ANAEMIA DUE TO THREE NOVEL SPTA1 MUTATIONS IN TWO COMPOUND HETEROZYGOUS UNRELATED PATIENTS.

EHA Library, Joan-LLuis Vives Corron, 266821

META-ANALYSIS USING DATA OF RED BLOOD CELL ENZYME ASSAY AND PROTEOME IN PATIENTS WITH DIAMOND-BLACKFAN ANEMIA

EHA Library, Taiju Utsugisawa, 266822